UTI Gold ETF
GOLDSHARE.NS News Today: Stay Updated with the Latest UTI Gold ETF News in Real Time
Find GOLDSHARE.NS news now at Meyka AI. Stay informed with the latest UTI Gold ETF stocks updates, including price news, market analysis, and expert insights.

ASX Stock Market April 22: Cochlear Crashes 40%, Dragging Index Down
ASX 200 drops 1% as Cochlear crashes 40% on earnings downgrade. Healthcare sector weakens amid market uncertainty and geopolitical tensions.

AEM Outperform Rating Held by CIBC April 22, 2026
CIBC maintains Outperform rating on AEM while lowering price target to $304 from $312. Stock trades at $203.09.

EDVMF Maintained at Outperform by CIBC, April 2026
CIBC maintained Endeavour Mining (EDVMF) at Outperform with price target raised to C$119 from C$117 on April 21, 2026.

GMINF Maintains Outperform at CIBC, April 22, 2026
CIBC maintains Outperform rating on GMINF, raising price target to C$62 from C$60 on April 21, 2026.

HBM Maintained at Outperform by CIBC, April 2026
CIBC maintains Outperform rating on HBM, raises price target to C$46 from C$42. Hudbay Minerals stock at $23.85.

Nikkei 225 hits record high as Trump extends Iran ceasefire, boosting risk appetite
The Nikkei 225 surged to a fresh record high as global investors reacted positively to news that Donald Trump extended the Iran ceasefire, easing geopolitical tensions and lifting market sentiment across Asia. Strong buying in export-heavy sectors, improved global outlook, and stable yen movement helped push the index above key resistance levels, with analysts now…

MCX Gold Price Decline April 22: Dollar Surge Pressures Bullion
MCX gold price decline April 22: Dollar strength and Fed rate expectations drive gold lower amid easing geopolitical tensions.

LUNMF: CIBC Maintains Neutral Rating, Raises Price Target April 2026
CIBC maintains Neutral rating on LUNMF, raises price target to C$41 from C$39. Lundin Mining trades at $27.27.

NEM Outperform Rating Maintained by CIBC April 2026
CIBC maintains Newmont (NEM) Outperform rating with price target lowered to $176 from $177 on April 21, 2026.